Paper9103439
Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells.
Vergelli M and 8 others. J Immunol, 1997. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells. Papers, record 9103439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9103439
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphocyte Activation | Major topic |
| Peptides | Major topic |
| T-Lymphocytes | Major topic |
| Amino Acid Sequence | |
| Humans | |
| Ligands | |
| Molecular Sequence Data |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37409132 | The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer. | Front Immunol | 2023 | https://conductscience.org/library/papers/37409132 | PubMed |
| 33091337 | HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis. | Cell | 2020 | https://conductscience.org/library/papers/33091337 | PubMed |
| 26401510 | Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions. | Ann Clin Transl Neurol | 2015 | https://conductscience.org/library/papers/26401510 | PubMed |
| 22888134 | Myelin basic protein-specific TCR/HLA-DRB5*01:01 transgenic mice support the etiologic role of DRB5*01:01 in multiple sclerosis. | J Immunol | 2012 | https://conductscience.org/library/papers/22888134 | PubMed |
| 18998128 | Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity? | Cancer Immunol Immunother | 2009 | https://conductscience.org/library/papers/18998128 | PubMed |
| 16906394 | An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity. | Cancer Immunol Immunother | 2007 | https://conductscience.org/library/papers/16906394 | PubMed |
| 11898528 | T cells, cytokines, and autoantigens in multiple sclerosis. | Curr Neurol Neurosci Rep | 2001 | https://conductscience.org/library/papers/11898528 | PubMed |
| 10319877 | Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. | Ann Neurol | 1999 | https://conductscience.org/library/papers/10319877 | PubMed |
| 9802984 | In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. | J Exp Med | 1998 | https://conductscience.org/library/papers/9802984 | PubMed |
| 9492986 | Activation of autoreactive T cells by peptides from human pathogens. | Curr Opin Immunol | 1997 | https://conductscience.org/library/papers/9492986 | PubMed |
| 9419364 | Heteroclitic proliferative responses and changes in cytokine profile induced by altered peptides: implications for autoimmunity. | Proc Natl Acad Sci U S A | 1998 | https://conductscience.org/library/papers/9419364 | PubMed |
| 9151902 | Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. | J Exp Med | 1997 | https://conductscience.org/library/papers/9151902 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9103439
GET https://conductscience.org/api/papers/v1/9103439/authors